Cargando…
A critical evaluation of health risk assessment of modified mycotoxins with a special focus on zearalenone
A comprehensive definition introducing the term “modified mycotoxins” to encompass all possible forms in which mycotoxins and their modifications can occur was recently proposed and has rapidly gained wide acceptance within the scientific community. It is becoming increasingly evident that exposure...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331505/ https://www.ncbi.nlm.nih.gov/pubmed/30209771 http://dx.doi.org/10.1007/s12550-018-0328-z |
_version_ | 1783387146318512128 |
---|---|
author | Lorenz, Nicole Dänicke, Sven Edler, Lutz Gottschalk, Christoph Lassek, Eva Marko, Doris Rychlik, Michael Mally, Angela |
author_facet | Lorenz, Nicole Dänicke, Sven Edler, Lutz Gottschalk, Christoph Lassek, Eva Marko, Doris Rychlik, Michael Mally, Angela |
author_sort | Lorenz, Nicole |
collection | PubMed |
description | A comprehensive definition introducing the term “modified mycotoxins” to encompass all possible forms in which mycotoxins and their modifications can occur was recently proposed and has rapidly gained wide acceptance within the scientific community. It is becoming increasingly evident that exposure to such modified mycotoxins due to their presence in food and feed has the potential to pose a substantial additional risk to human and animal health. Zearalenone (ZEN) is a well-characterized Fusarium toxin. Considering the diversity of modified forms of ZEN occurring in food and feed, the toxicologically relevant endocrine activity of many of these metabolites, and the fact that modified forms add to a dietary exposure which approaches the tolerable daily intake by free ZEN alone, modified forms of ZEN present an ideal case study for critical evaluation of modified mycotoxins in food safety. Following a summary of recent scientific opinions of EFSA dealing with health risk assessment of ZEN alone or in combination with its modified forms, uncertainties and data gaps are highlighted. Issues essential for evaluation and prioritization of modified mycotoxins in health risk assessment are identified and discussed, including opportunities to improve exposure assessment using biomonitoring data. Further issues such as future consideration of combinatory effects of the parent toxin with its modified forms and also other compounds co-occurring in food and feed are addressed. With a particular focus on ZEN, the most pressing challenges associated with health risk assessment of modified mycotoxins are identified and recommendations for further research to fill data gaps and reduce uncertainties are made. |
format | Online Article Text |
id | pubmed-6331505 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-63315052019-01-27 A critical evaluation of health risk assessment of modified mycotoxins with a special focus on zearalenone Lorenz, Nicole Dänicke, Sven Edler, Lutz Gottschalk, Christoph Lassek, Eva Marko, Doris Rychlik, Michael Mally, Angela Mycotoxin Res Original Article A comprehensive definition introducing the term “modified mycotoxins” to encompass all possible forms in which mycotoxins and their modifications can occur was recently proposed and has rapidly gained wide acceptance within the scientific community. It is becoming increasingly evident that exposure to such modified mycotoxins due to their presence in food and feed has the potential to pose a substantial additional risk to human and animal health. Zearalenone (ZEN) is a well-characterized Fusarium toxin. Considering the diversity of modified forms of ZEN occurring in food and feed, the toxicologically relevant endocrine activity of many of these metabolites, and the fact that modified forms add to a dietary exposure which approaches the tolerable daily intake by free ZEN alone, modified forms of ZEN present an ideal case study for critical evaluation of modified mycotoxins in food safety. Following a summary of recent scientific opinions of EFSA dealing with health risk assessment of ZEN alone or in combination with its modified forms, uncertainties and data gaps are highlighted. Issues essential for evaluation and prioritization of modified mycotoxins in health risk assessment are identified and discussed, including opportunities to improve exposure assessment using biomonitoring data. Further issues such as future consideration of combinatory effects of the parent toxin with its modified forms and also other compounds co-occurring in food and feed are addressed. With a particular focus on ZEN, the most pressing challenges associated with health risk assessment of modified mycotoxins are identified and recommendations for further research to fill data gaps and reduce uncertainties are made. Springer Berlin Heidelberg 2018-09-13 2019 /pmc/articles/PMC6331505/ /pubmed/30209771 http://dx.doi.org/10.1007/s12550-018-0328-z Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Lorenz, Nicole Dänicke, Sven Edler, Lutz Gottschalk, Christoph Lassek, Eva Marko, Doris Rychlik, Michael Mally, Angela A critical evaluation of health risk assessment of modified mycotoxins with a special focus on zearalenone |
title | A critical evaluation of health risk assessment of modified mycotoxins with a special focus on zearalenone |
title_full | A critical evaluation of health risk assessment of modified mycotoxins with a special focus on zearalenone |
title_fullStr | A critical evaluation of health risk assessment of modified mycotoxins with a special focus on zearalenone |
title_full_unstemmed | A critical evaluation of health risk assessment of modified mycotoxins with a special focus on zearalenone |
title_short | A critical evaluation of health risk assessment of modified mycotoxins with a special focus on zearalenone |
title_sort | critical evaluation of health risk assessment of modified mycotoxins with a special focus on zearalenone |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331505/ https://www.ncbi.nlm.nih.gov/pubmed/30209771 http://dx.doi.org/10.1007/s12550-018-0328-z |
work_keys_str_mv | AT lorenznicole acriticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone AT danickesven acriticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone AT edlerlutz acriticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone AT gottschalkchristoph acriticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone AT lassekeva acriticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone AT markodoris acriticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone AT rychlikmichael acriticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone AT mallyangela acriticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone AT lorenznicole criticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone AT danickesven criticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone AT edlerlutz criticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone AT gottschalkchristoph criticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone AT lassekeva criticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone AT markodoris criticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone AT rychlikmichael criticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone AT mallyangela criticalevaluationofhealthriskassessmentofmodifiedmycotoxinswithaspecialfocusonzearalenone |